Systemic sclerosis & Raynaud's

Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease

Rheumatology (Oxford)Published Cohort study

Authors' conclusion

PPF occurred in a third of our incident SSc-ILD cohort; however, its occurrence was significantly associated with mortality

Study context

Population
Incident SSc-ILD cases (new characteristic fibrotic changes on chest HRCT)
Outcome
Frequency of PPF (2022 American Thoracic Society definition)
Follow-up
Within a 12-month period after ILD diagnosis
Methodological detailsincident cohort, generalised estimating equations, accelerated failure time regression modelling
  • Incident cohort
  • Generalised estimating equations
  • Accelerated failure time regression modelling

Main finding

As reported in the abstract

PPF · within 12 months after ILD diagnosis

Incident SSc-ILD

38.8%

180 events

Observational data: associations, not effects.

Further findings

Determinants of progressive pulmonary fibrosis (PPF) · 12 months after interstitial lung disease (ILD) diagnosis

OR (95% CI)P value
Older ageGeneralised estimating equations1.02 (1.00–1.03)P = 0.011
dcSScGeneralised estimating equations1.54 (1.06–2.25)P = 0.024
Anticentomere antibodyGeneralised estimating equations0.51 (0.29–0.91)P = 0.021
anti-Scl-70 antibodyGeneralised estimating equations1.46 (1.01–2.09)P = 0.043
Raised CRPGeneralised estimating equations1.29 (0.99–1.68)P = 0.064
GORDGeneralised estimating equations1.18 (0.57–2.42)P = 0.658
DysphagiaGeneralised estimating equations1.17 (0.57–2.40)P = 0.664

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford). Published 19 September 2023. doi:10.1093/rheumatology/kead491

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.